EARLY DETECTION & DIAGNOSIS NEWSLETTER Hi Voornaam,
Welcome to your first early detection and diagnosis research newsletter for 2022. As the pandemic enters its third year, we continue to face challenges across cancer research, diagnosis, and treatment. Our CEO Michelle Mitchell highlighted the looming crisis in a recent blogpost for the NHS Confederation, noting that now is the time to embrace innovation and action to tackle these challenges because cancer wont wait.
We'll continue to support our scientific community, patients, and the public. New discoveries leading to earlier detection of cancers and improving pathways and behaviours to speed diagnosis will create better outcomes. Through research, we move towards a future of increased cancer survival and we're extremely grateful to our community for your continued hard work and dedication during these unprecedented times. As ever, this newsletter highlights some of your amazing achievements alongside exciting opportunities for funding, networking, and collaboration. Wishing you all a great start to 2022 and success throughout the year. Kind regards, David Crosby,
Head of Prevention and Early Detection Research
Cancer Research UK |
|
|---|
|
|---|
|
|
UPCOMING FUNDING DEADLINES |
|
|---|
|
|---|
|
|
RECENTLY FUNDED AWARDS We're pleased to share the outcomes of our most recent Early Detection and Diagnosis Committee meeting, where one Programme Award, four Project Awards, and nine Primer Awards were supported for a total investment of 5 million in new research.
As always, if youd like to discuss an idea for a funding application, please get in touch and a member of the team will be happy to advise. |
|
|---|
|
|---|
|
|
OBSERVE A COMMITTEE MEETING As part of our commitments to Equality, Diversity and Inclusion in Research and to train the next generation of leaders in the early detection field, we're offering early-career researchers the opportunity to observe one of our Committee meetings, held in May and November each year. We hope that through this experience, early-career researchers can learn more about how funding decisions are made, which in turn will help them to develop their own successful research proposals in the future. If you're interested in observing a meeting, please get in touch with your CV and a brief summary of why the opportunity would be beneficial to you. We regret that PhD students are not eligible to observe the meetings.
|
|
|---|
|
|---|
|
|
 CANCER RESEARCH UK-ROYAL SOCIETY OF CHEMISTRY NETWORKING EVENT This years CRUK-RSC workshop and networking event will take place at Burlington House, London, on Friday 6 May. Applications to attend are welcome from early and mid-career researchers, established independent researchers and industry researchers working in the fields of analytical science, material science, cancer biology, data science, clinicians, behavioural scientists and health professionals. The event will focus on the challenges and opportunities of wearable technologies and real-time health monitoring for the early detection of cancer. This is an exciting opportunity to foster new interdisciplinary collaborations for early detection funding opportunities. Hear from previous attendees about their experience at this event. |
|
|---|
|  REGISTER INTEREST FOR THE EARLY DETECTION OF CANCER CONFERENCE 2022 This years Early Detection of Cancer Conference, held in partnership with the Knight Cancer Institute at OHSU and the Canary Center at Stanford, will take place in Portland, Oregon from 1820 October.
Register your interest to ensure that you're the first to know when booking is available, and to stay up-to-date with all of the latest conference information. |
|
|---|
|
|---|
|
|
| | DELIVERING ON THE PROMISE OF EARLY DETECTION WITH LIQUID BIOPSIES In The British Journal of Cancers Special Issue on Liquid Biopsies, David Crosby, our Head of Prevention and Early Detection Research discusses the huge potential of liquid biopsy approaches for cancer early detection. David highlights how CRUK-funded research is driving progress in this area but acknowledges that there are still numerous challenges to overcome. Along with other early detection approaches, research into liquid biopsies is a key part of our strategy and we welcome more consideration not only into further technological development, but how such tests will be translated and trialled in real-world clinical settings. |
|
|---|
|
|---|
|
|
 CHANGES TO OUR OPEN ACCESS POLICY Making published research available in an open and unrestricted way maximises its impact by facilitating rapid sharing of knowledge, promoting innovation and ultimately ensuring that patients can access better treatments sooner. As of 1 January, were taking the steps we previously announced to make our research open access. This means all research we fund, in whole or in part, should now be made open access immediately on publication.
If you have questions about these changes, check out our FAQs or get in touch. |
|
|---|
|  OUR FUTURE HEALTH THE UKS LARGEST HEALTH RESEARCH PROGRAMME Were proud to be endorsing the pilot phase of Our Future Health the UKs largest health research programme as it begins work to transform the prevention, detection, and treatment of diseases, including cancer. Our Future Health aims to recruit five million adult volunteers, from all backgrounds, to participate in the research programme. By joining the voluntary research programme, people will be able to contribute to the most comprehensive picture of health ever captured in the UK. Researchers from across academia, industry and the NHS will be able to apply to use Our Future Health data and samples for their crucial research. |
|
|---|
|
|---|
|
|
| | VIRTUAL SPOTLIGHT EVENT ON CANCER AWARENESS MEASURE Join us on 9 February for a webinar focused on the findings of the Cancer Awareness Measure (CAM) September 2021 Survey. The survey is designed to measure the publics awareness of the symptoms and risk factors of cancer as well as the barriers to seeking help. Dr Vicky Whitelock from our Cancer Intelligence Team will be joined by the MAINROUTE team from The University of Oxford to reflect on the latest findings. |
|
|---|
|
|---|
|
|
| Been forwarded this email? Subscribe to our newsletter to stay up to date. |
|---|
| |
|---|
|
|
|
